Loading...
XHKG
8049
Market cap175mUSD
Jul 10, Last price  
2.46HKD
1D
0.00%
1Q
5.58%
Jan 2017
51.85%
IPO
79.56%
Name

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

Chart & Performance

D1W1MN
XHKG:8049 chart
P/E
6.00
P/S
1.32
EPS
0.36
Div Yield, %
11.09%
Shrs. gr., 5y
Rev. gr., 5y
7.70%
Revenues
902m
+2.35%
69,522,00097,284,000127,124,000152,766,000200,630,000274,294,000353,247,000457,746,000601,715,000539,134,000654,119,000645,303,000647,672,000645,885,000622,250,000705,456,000841,586,000841,545,000881,157,000901,869,000
Net income
199m
+7.94%
3,037,00012,378,00014,989,00022,076,00035,891,00050,893,00058,754,00079,274,000132,785,000117,638,000142,670,000144,402,000161,216,000144,726,000126,558,000143,283,000193,565,000148,207,000184,250,000198,884,000
CFO
313m
+42.61%
29,357,00017,096,00040,643,00014,397,00055,169,00022,909,00050,893,00082,694,00049,434,000151,613,000123,823,000146,507,000138,813,000132,509,000151,227,000215,090,000203,992,000315,947,000219,652,000313,243,000
Dividend
Jun 24, 20250.27292 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jilin Province Huinan Changlong Bio-pharmacy Company Limited focuses on the manufacturing and sale of traditional Chinese medicines and various pharmaceutical products within the People's Republic of China. The company's extensive product portfolio includes a wide range of dosage forms such as tablets, capsules, and pills, as well as specialized items like Chinese medicine pretreatment and extraction products. They also provide various injectable solutions, including powders for injection, lyophilized powders for injection, and small volume liquid injections, along with active pharmaceutical ingredients (APIs) and granules. These products are primarily sold under the "Changlong" and "Qing Tong" brand names. Established in 1989, and headquartered in Kowloon, Hong Kong, the company was previously known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited.
IPO date
May 24, 2001
Employees
928
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT